AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30866672 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122873
Study 28884798 — intervention group
Group type: EXPERIMENTAL
Intervention: Proper care and good hygiene of the normal mature neonatal skin
Number of subjects: 0
Study 28884798 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimizing epidermal barrier integrity (bathing and using emollient)
Number of subjects: 0
Study 28884798 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby bath products and baby wipes
Number of subjects: 0
Study 28884798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleansers specially designed for baby's skin (pH neutral and very mild)
Number of subjects: 0
Study 25445632 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine + nitrate (6 g L-arginine and 614 mg nitrate)
Number of subjects: 9
Study 25445632 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate alone (614 mg nitrate)
Number of subjects: 9
Study 25445632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 25445632 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 9
Study 25445632 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine + nitrate and nitrate alone
Number of subjects: 9
Study 24621441 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplements
Number of subjects: 2118
Study 24621441 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplements
Number of subjects: 2118
Study 24621441 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin use
Number of subjects: 2118
Study 24621441 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplements in combination with multivitamin
Number of subjects: 2118
Study 22028420 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictogram-enhanced medication information
Number of subjects: 82
Study 22028420 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling (Control)
Number of subjects: 82
Study 19302637 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention with weekly meetings or telephone counselling and free nicotine replacement therapy (NRT) initiated 4 weeks prior to surgery.
Number of subjects: 117
Study 19302637 — intervention group
Group type: COMPARATOR
Intervention: Control group received standard care.
Number of subjects: 117
Study 19302637 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention with weekly meetings or telephone counselling and free nicotine replacement therapy (NRT) after 1 year.
Number of subjects: 117
Study 19302637 — intervention group
Group type: COMPARATOR
Intervention: Control group received standard care after 1 year.
Number of subjects: 117
Study 17515020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) for 8 weeks
Number of subjects: 15
Study 17515020 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-depressed post-CABG women)
Number of subjects: 15
Study 15482971 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative examination of perceptions of young fathers toward early childbearing issues.
Number of subjects: 0
Study 11246659 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg LJP 394 weekly
Number of subjects: 58
Study 11246659 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg LJP 394 weekly
Number of subjects: 58
Study 11246659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 9543190 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐min scaling (method 1)
Number of subjects: 11
Study 9543190 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐min scaling and 1 min instrumentation with a perio‐diamond bur (15 microm) (method 2)
Number of subjects: 11
Study 9543190 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐min scaling, 1‐min instrumentation with a perio‐diamond bur (15 microm) and 1 min with an air abrasive system (method 3)
Number of subjects: 11
Study 9543190 — intervention group
Group type: COMPARATOR
Intervention: no treatment (control)
Number of subjects: 11
Study 8289849 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (45 minutes per day, 5 days per week for 12 weeks)
Number of subjects: 33
Study 8289849 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 33
Study 8289849 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 33
Study 8289849 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study 3353043 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulus
Number of subjects: 132
Study 3353043 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulus
Number of subjects: 132
Study 30520017 — intervention group
Group type: EXPERIMENTAL
Intervention: Perpendicular approach
Number of subjects: 16
Study 30520017 — intervention group
Group type: COMPARATOR
Intervention: Parallel approach
Number of subjects: 16
Study 30520017 — intervention group
Group type: EXPERIMENTAL
Intervention: Both approaches
Number of subjects: 16
Study 25382805 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectra Optia
Number of subjects: 32
Study 25382805 — intervention group
Group type: COMPARATOR
Intervention: COBE Spectra
Number of subjects: 32
Study 25382805 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 32
Study 24660604 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduning injection and Western Medicine (Group C)
Number of subjects: 360
Study 24660604 — intervention group
Group type: COMPARATOR
Intervention: Western Medicine (Group A)
Number of subjects: 360
Study 24660604 — intervention group
Group type: COMPARATOR
Intervention: Reduning injection (Group B)
Number of subjects: 360
Study 21261434 — intervention group
Group type: EXPERIMENTAL
Intervention: Craving module intervention
Number of subjects: 776
Study 19691852 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mL of intravenous-grade 70% ethanol into each lumen of the catheter once a week
Number of subjects: 112
Study 19691852 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin locks only
Number of subjects: 112
Study 16501263 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment questions in Web-based modules
Number of subjects: 121
Study 15592192 — intervention group
Group type: COMPARATOR
Intervention: Noncorrected Tc-99m tetrofosmin SPECT
Number of subjects: 33
Study 15592192 — intervention group
Group type: EXPERIMENTAL
Intervention: Attenuation-corrected Tc-99m tetrofosmin SPECT
Number of subjects: 33
Study 15592192 — intervention group
Group type: COMPARATOR
Intervention: FDG SPECT
Number of subjects: 33
Study 11450868 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 3 g and clavulanic acid 750 mg, 1 dose daily for 2 days
Number of subjects: 15
Study 9496918 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive amalgam restorations with auxiliary retention methods
Number of subjects: 300
Study 9496918 — intervention group
Group type: COMPARATOR
Intervention: Age of patient
Number of subjects: 300
Study 8056226 — intervention group
Group type: EXPERIMENTAL
Intervention: Video plus discussion
Number of subjects: 201
Study 8056226 — intervention group
Group type: EXPERIMENTAL
Intervention: Video alone
Number of subjects: 201
Study 8056226 — intervention group
Group type: COMPARATOR
Intervention: Discussion alone
Number of subjects: 201
Study 8056226 — intervention group
Group type: EXPERIMENTAL
Intervention: Video plus discussion and Video alone
Number of subjects: 201
Study 8056226 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety levels
Number of subjects: 201
Study 2543656 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined progestin and estrogen (medroxyprogesterone acetate, 20 mg tid, and Premarin, 1.25 mg bid)
Number of subjects: 9
Study 2543656 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 9
Study 30342058 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual stress challenges (DSC) during exercise
Number of subjects: 14
Study 30342058 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone (EA)
Number of subjects: 14
Study 28754155 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress CMR followed by coronary angiography if myocardial ischemia is detected
Number of subjects: 0
Study 28754155 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic coronary angiography and subsequent revascularization according to current guidelines
Number of subjects: 0
Study 28754155 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine stress CMR
Number of subjects: 0
Study 28754155 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic coronary angiography
Number of subjects: 0
Study 26444863 — intervention group
Group type: EXPERIMENTAL
Intervention: Online monthly self-assessments + 12-month access to a 4-week online automated cognitive behaviour therapy program for binge drinking and depression (DEAL)
Number of subjects: 369
Study 26444863 — intervention group
Group type: EXPERIMENTAL
Intervention: Online monthly assessment + DEAL + 12-month access to a social networking site (Breathing Space)
Number of subjects: 369
Study 26444863 — intervention group
Group type: COMPARATOR
Intervention: Online monthly self-assessments
Number of subjects: 369
Study 24565090 — intervention group
Group type: EXPERIMENTAL
Intervention: Propovan®
Number of subjects: 16
Study 24565090 — intervention group
Group type: COMPARATOR
Intervention: Diprivan®
Number of subjects: 16
Study 24565090 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 16
Study 21390576 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine therapy for activating blood and dredging collaterals (ABDC)
Number of subjects: 34
Study 21390576 — intervention group
Group type: COMPARATOR
Intervention: Western medical conventional treatment for anti‐inflammation and immunosuppression
Number of subjects: 34
Study 19718402 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive oral hygiene care (tooth brushing instruction, oral health education, supra-gingival scaling conducted every month for 6 months)
Number of subjects: 75
Study 19718402 — intervention group
Group type: COMPARATOR
Intervention: Control group (tooth brushing instruction, oral health education, supra-gingival scaling conducted twice at baseline and sixth month)
Number of subjects: 75
Study 17230495 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy and relaxation in addition to standardized glucocorticoid therapy
Number of subjects: 69
Study 17230495 — intervention group
Group type: COMPARATOR
Intervention: Standardized glucocorticoid therapy (Control)
Number of subjects: 69
Study 15791376 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete VATS (C-VATS, n = 20)
Number of subjects: 39
Study 15791376 — intervention group
Group type: COMPARATOR
Intervention: Assisted VATS (A-VATS, n = 19)
Number of subjects: 39
Study 15791376 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete VATS (C-VATS)
Number of subjects: 39
Study 11333065 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium 20 mg/kg/day
Number of subjects: 15
Study 9071482 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral proximal femur BMD measurement at a cutoff T score of -1
Number of subjects: 266
Study 9071482 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral proximal femur BMD measurement
Number of subjects: 266
Study 8376915 — intervention group
Group type: EXPERIMENTAL
Intervention: S 5682
Number of subjects: 100
Study 8376915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 3946364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg/6 h intravenously to a maximum of 400 mg/4 h
Number of subjects: 44
Study 3946364 — intervention group
Group type: COMPARATOR
Intervention: Mylanta II 30 ml/h through a nasogastric tube to a maximum of 90 ml/h
Number of subjects: 44
Study 3946364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 44
Study 3946364 — intervention group
Group type: COMPARATOR
Intervention: Mylanta II
Number of subjects: 44
Study 31979283 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of Eleutherococcus senticosus (ES) and Drynaria fortunei (DR) extracts for 12 weeks
Number of subjects: 0
Study 31979283 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of ES and DR extracts
Number of subjects: 0
Study 29365351 — intervention group
Group type: EXPERIMENTAL
Intervention: icosapent ethyl 4 g/d
Number of subjects: 80
Study 27343782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine with 1mL sufentanil (5μg) in group 4
Number of subjects: 60
Study 27343782 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal bupivacaine with 1mL saline (placebo) in group 3
Number of subjects: 60
Study 27343782 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal bupivacaine with 1mL saline (placebo) in group 1
Number of subjects: 60
Study 27343782 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine with 1mL sufentanil (5μg) in group 2
Number of subjects: 60
Study 24824018 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterofundin plus 1% glucose
Number of subjects: 240
Study 24824018 — intervention group
Group type: COMPARATOR
Intervention: Normal saline plus 1% glucose
Number of subjects: 240
Study 24824018 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Sterofundin and Normal saline)
Number of subjects: 240
Study 22209106 — intervention group
Group type: EXPERIMENTAL
Intervention: superiorly based vermillion‐mucosal flap and orbicularis oris reconstruction with linear closure
Number of subjects: 31
Study 22209106 — intervention group
Group type: EXPERIMENTAL
Intervention: superiorly based vermillion‐mucosal flap and orbicularis oris reconstruction with Z‐plasty (both superiorly rotated and inferiorly rotated)
Number of subjects: 31
Study 20618679 — intervention group
Group type: EXPERIMENTAL
Intervention: Incandescent with dimmer switch slowly increasing the level of light (ISL)
Number of subjects: 8
Study 20618679 — intervention group
Group type: COMPARATOR
Intervention: Fluorescent with on/off switch rapidly increasing the level of light (FRL)
Number of subjects: 8
Study 20618679 — intervention group
Group type: COMPARATOR
Intervention: Incandescent with on/off switch rapidly increasing the level of light (IRL)
Number of subjects: 8
Study 18399021 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 33
Study 18399021 — intervention group
Group type: COMPARATOR
Intervention: Health visitor-delivered non-directive counselling
Number of subjects: 33
Study 16096450 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia of 33 degrees C
Number of subjects: 60
Study 16096450 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (core temperature kept below 38 degrees C with antipyretics and physical means)
Number of subjects: 60
Study 12418740 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic dual chamber pacing (DDD)
Number of subjects: 21
Study 10323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Normocortisolism with hydrocortisone (0.4 mg/kg over 19.5 h)
Number of subjects: 7
Study 10323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocortisolism (24 h withdrawal of hydrocortisone, followed by 19.5 h saline infusion)
Number of subjects: 7
Study 10323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Normocortisolism with naloxone (25 microg/kg x h during last 6.5 h)
Number of subjects: 7
Study 10323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocortisolism with naloxone
Number of subjects: 7
Study 10323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocortisolism
Number of subjects: 7
Study 10323386 — intervention group
Group type: EXPERIMENTAL
Intervention: Normocortisolism with naloxone
Number of subjects: 7
Study 8532302 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-patterned flash visual evoked potentials (VEP's) at several different temporal frequency rates
Number of subjects: 33
Study 8532302 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant analysis (DA)
Number of subjects: 33
Study 1458666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% amorolfine cream
Number of subjects: 725
Study 1458666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% amorolfine cream
Number of subjects: 725
Study 1458666 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% amorolfine cream
Number of subjects: 725
Study 6735830 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic ticarcillin
Number of subjects: 0
Study 6735830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31112677 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen 60 minutes before surgery
Number of subjects: 75
Study 31112677 — intervention group
Group type: COMPARATOR
Intervention: IV placebo (100 mL of saline) before surgery
Number of subjects: 75
Study 31112677 — intervention group
Group type: COMPARATOR
Intervention: IV placebo (100 mL of saline) before and after surgery
Number of subjects: 75
Study 31112677 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ibuprofen 60 minutes after surgery
Number of subjects: 75
Study 30407151 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroids (20 mg for ages 2-5 years, 30 mg for ages 6-8 years)
Number of subjects: 389
Study 30407151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 389
Study 30407151 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral steroids
Number of subjects: 389
Study 26751016 — intervention group
Group type: EXPERIMENTAL
Intervention: AGS‐004
Number of subjects: 54
Study 26751016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 25222041 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 10 mg/kg/day
Number of subjects: 75
Study 25222041 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E 10 IU/kg/day
Number of subjects: 75
Study 25222041 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 75
Study 21593802 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Contingency (SC) intervention
Number of subjects: 62
Study 21593802 — intervention group
Group type: COMPARATOR
Intervention: Standard Behavioral Weight Loss (SBWL)
Number of subjects: 62
Study 21593802 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Contingency (SC) intervention (participants who did not meet weight goals)
Number of subjects: 62
Study 21593802 — intervention group
Group type: COMPARATOR
Intervention: Standard Behavioral Weight Loss (SBWL) (participants who did not meet weight goals)
Number of subjects: 62
Study 21593802 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful Social Contingency (SC) participants
Number of subjects: 62
Study 21593802 — intervention group
Group type: COMPARATOR
Intervention: Successful Standard Behavioral Weight Loss (SBWL) participants
Number of subjects: 62
Study 20374988 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional Work Experience (TWE) services
Number of subjects: 89
Study 20374988 — intervention group
Group type: COMPARATOR
Intervention: Job Placement (JP) services
Number of subjects: 89
Study 18940369 — intervention group
Group type: EXPERIMENTAL
Intervention: Flower essences presented as a spiritual therapy
Number of subjects: 251
Study 18940369 — intervention group
Group type: EXPERIMENTAL
Intervention: Flower essences presented as an affirmation (nonspiritual therapy)
Number of subjects: 251
Study 18940369 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (spiritual and nonspiritual)
Number of subjects: 251
Study 18940369 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonenhanced ritual group
Number of subjects: 251
Study 16183125 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 0.5% ophthalmic solution
Number of subjects: 50
Study 16183125 — intervention group
Group type: COMPARATOR
Intervention: Gatifloxacin 0.3% ophthalmic solution
Number of subjects: 50
Study 12577188 — intervention group
Group type: EXPERIMENTAL
Intervention: hPTH (1‐34) for 1 year and HRT
Number of subjects: 51
Study 12577188 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with only HRT
Number of subjects: 51
Study 10376113 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg dehydroepiandrosterone
Number of subjects: 17
Study 10376113 — intervention group
Group type: EXPERIMENTAL
Intervention: 450 mg dehydroepiandrosterone
Number of subjects: 17
Study 10376113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 8888928 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified breast milk (FM-85, Nestle)
Number of subjects: 11
Study 8888928 — intervention group
Group type: COMPARATOR
Intervention: Unfortified breast milk
Number of subjects: 11
Study 2064115 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg prednisone daily (n = 8)
Number of subjects: 16
Study 2064115 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily (n = 8)
Number of subjects: 16
Study 6862345 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-Dihydergot (2 X 5000 IU sodium heparin with 0.5 mg dihydroergotamine)
Number of subjects: 532
Study 6862345 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium heparin (2 X 5000 IU calcium heparin)
Number of subjects: 532
Study 6862345 — intervention group
Group type: COMPARATOR
Intervention: Acenocoumarol (Sintrom)
Number of subjects: 532
Study 6862345 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin alone or in combination with dihydroergotamine
Number of subjects: 532
Study 30414840 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (BoNTA) 250 units
Number of subjects: 130
Study 30414840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 30414840 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (BoNTA)
Number of subjects: 130
Study 27924618 — intervention group
Group type: EXPERIMENTAL
Intervention: Low physical activity levels
Number of subjects: 513
Study 27924618 — intervention group
Group type: COMPARATOR
Intervention: Any tobacco use
Number of subjects: 513
Study 27924618 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall CVD-related outcomes
Number of subjects: 513
Study 25706340 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative centralized (CC) reminder/recall notifications
Number of subjects: 18235
Study 25706340 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative centralized (CC) reminder/recall notifications endorsed by primary care practices
Number of subjects: 18235
Study 25706340 — intervention group
Group type: COMPARATOR
Intervention: Practice-based (PB) reminder/recall notifications
Number of subjects: 18235